enow.com Web Search

  1. Ads

    related to: fda approved soravtansine gynx doctors directory near me map michigan

Search results

  1. Results from the WOW.Com Content Network
  2. Mirvetuximab soravtansine - Wikipedia

    en.wikipedia.org/wiki/Mirvetuximab_soravtansine

    Mirvetuximab soravtansine, sold under the brand name Elahere, is a medication used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. [ 2 ] [ 5 ] Mirvetuximab soravtansine is a folate receptor alpha directed antibody and microtubule inhibitor conjugate.

  3. FDA approves weight-loss drug to treat sleep apnea - AOL

    www.aol.com/fda-approves-weight-loss-drug...

    The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...

  4. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

  5. Zepbound Weight Loss Medication Approved by FDA to Treat ...

    www.aol.com/fda-approves-weight-loss-medication...

    The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.

  6. What does growth hormone therapy treat? What an ... - AOL

    www.aol.com/does-growth-hormone-therapy-treat...

    In adults, GH therapy has been FDA-approved to treat GHD and HIV-related muscle loss. What causes growth hormone deficiency? GHD is a relatively rare condition. Slowed growth, short stature, and ...

  7. Ivacaftor - Wikipedia

    en.wikipedia.org/wiki/Ivacaftor

    The most common adverse reactions experienced by patients who received ivacaftor in the pooled placebo-controlled Phase III studies were abdominal pain (15.6% versus 12.5% on placebo), diarrhoea (12.8% versus 9.6% on placebo), dizziness (9.2% versus 1.0% on placebo), rash (12.8% versus 6.7% on placebo), upper respiratory tract reactions (including upper respiratory tract infection, nasal ...

  1. Ads

    related to: fda approved soravtansine gynx doctors directory near me map michigan
  1. Related searches fda approved soravtansine gynx doctors directory near me map michigan

    fda approved soravtansine gynx doctors directory near me map michigan images